A study on the effects of the consumption of alcohol on the patients with type 2 diabetes at the Huazhong University of Science and Technology shows that the consumption of wine is more helpful when compared with beer or spirits consumption for the patients with type 2 diabetes.
There may be a greater risk of severe hypoglycemia if more alcohol is consumed. The lead author of the study was Dr. Jin Huang. The study was published in the Journal of Diabetes Investigation.
iGlarLixi is a combination drug for the treatment of type 2 diabetes (T2D). This drug is manufactured by the Zealand Pharma. This drug was recommended for approval by the US FDA panel.
The drug manufacturer says that this drug is under the regulatory review in Europe. The drug is a combination of Lantus (insulin glargine. Sanofi) and the Lyxumia (lixisenatide. GLP-1 drug). Those patients who are taking the insulin or a GLP-1 drug to control the blood sugar levels would be given preference.
Earlier, the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has approved the Novo Nordisk drug (named as IDegLira), which is similar to iGlarLixi.
The researchers at the University of Texas Medical Branch (UTMB), Galveston, have found a molecular mechanism involved in diabetic cardiomyopathy in patients with diabetes.
Heart disease is the number one cause of death for patients with diabetes. A patient with diabetes is at a higher risk of cardiovascular diseases. This is due to the damage to the heart muscle, causing a restricted blood circulation.
Researchers have identified an RNA binding protein Rbfox2. This may help the researchers in the development of better tools to manage the diabetic cardiomyopathy.
The lead author of the study was N Muge Kuyumcu-Martinez, an Assistant Professor at the University of Texas Medical Branch (UTMB), Galveston. The study was published in the journal Cell Reports.
The researchers from the University of Pennsylvania School of Nursing have found a deficiency of 25-hydroxyvitamin D (25 hydroxy vitamin D) among Caucasian children with a healthy weight.
The authors say that the study underlines the importance of screening of 25-hydroxyvitamin D levels in all children with type 1 diabetes. The research was published in the Diabetes Research and Clinical Practice.
The researchers at the University of Lincoln, the United Kingdom have identified an unknown 5th molecule. The immune system attacks this molecule in patients with type 1 diabetes.
An earlier study has found that the immune system attacks five key targets in the patients with type 1 diabetes (T1D). The earlier study has already discovered four molecules. They are
Scientists are trying to identify the fifth molecule for the past 20 years. The previous name for this molecule was Glima. Now, the scientists have found that it is a human protein and named as Tetraspanin-7. Tetraspanin-7 is a protein molecule and it can accurately identify the risk of type 1 diabetes in the people.
The lead author of the study was Dr. Michael Christie, the University of Lincoln. The study was published in the Diabetes, the Journal of the American Diabetes Association.
In an event hosted by the Jamie Reed, Copeland MP and Theresa May, Home Secretary, JDRF have announced that £97m will be spent on diabetes research in the UK. The money is being provided by seven funders.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.